Air France KLM Martinair Cargo and Envirotainer Collaborate on Sustainability

Article

Air France KLM Martinair Cargo and Envirotainer are collaborating on more sustainable air transport of pharmaceuticals

Air France KLM Martinair Cargo (AFKLMP Cargo) and Envirotainer—provider of secure cold-chain solutions for the air transportation of pharmaceuticals—are collaborating on more sustainable air transport of pharmaceuticals, it was revealed in a Jan. 18, 2021 press release.

The companies have been partners for a long time, and each has a strong focus on sustainability. With this announcement, the companies have specified that they will intensify their partnership to strengthen their initiatives for sustainability through collaboration.

AFKLMP Cargo will be implementing in its booking system the new Envirotainer Releye container, which is reported to deliver up to 90% reduction in CO2 emissions compared with other available passive solutions when based on life-cycle analysis. Envirotainer will be investing in Sustainable Aviation Fuel (SAF), which is produced from sustainable feedstock and is claimed to reduce CO2 emissions by up to 85% when compared with conventional jet fuel.

“We are very happy that a close partner of ours since many years keeps delivering top quality service and secures that the pharmaceutical industry, together with us, provides further capacity of latest technology,” said Don Harrison, head of Global Key Accounts, Airlines at Envirotainer, in the press release.

“We really appreciate our long-term partnership with Envirotainer,” added Marcel Kuijn, global head of Pharmaceutical Logistics at AFKLMP Cargo, in the press release. “Sustainability and Pharmaceuticals are among our strategic focus areas. That is why this initiative is of such great importance to us.”

Source: Envirotainer

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content